Raymond James Financial
RGNX icon

Raymond James Financial’s Regenxbio RGNX Stock Holding History

Raymond James Financial’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Sell
92,588
-8,657
-9% -$71.8K ﹤0.01% 3928
2026
Q1 		$848K Buy
101,245
+15,244
+18% +$160K ﹤0.01% 3974
2025
Q4 		$1.24M Sell
86,001
-9,277
-10% -$116K ﹤0.01% 3639
2025
Q3 		$919K Sell
95,278
-16,219
-15% -$143K ﹤0.01% 3734
2025
Q2 		$915K Buy
111,497
+12,115
+12% +$101K ﹤0.01% 3645
2025
Q1 		$711K Buy
99,382
+25,872
+35% +$192K ﹤0.01% 3712
2024
Q4 		$568K Buy
+73,510
New +$690K ﹤0.01% 3830

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Raymond James Financial's RGNX Position: Q2 2026 in Review

Raymond James Financial reduced its Regenxbio (RGNX) stake by 8.6% in Q2 2026, selling an estimated $71.8K and leaving 92,588 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #3928.

Raymond James Financial first reported a position in RGNX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.24M in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Raymond James Financial held 92,588 shares of Regenxbio worth $1.11M as of Q2 2026.
  • Raymond James Financial sold 8,657 Regenxbio shares in Q2 2026, an estimated $71.8K.
  • Regenxbio made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3928 holding.
  • Raymond James Financial first reported a position in Regenxbio in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Regenxbio position peaked at $1.24M in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.